Insiders Anagenics Limited

Equities

Delayed Australian S.E. Other stock markets 02:53:43 21/05/2024 BST			5-day change	1st Jan Change
0.006 ^AUD	-14.29%		-14.29%	-68.42%

03-08	Anagenics Appoints CEO	MT
02-26	Anagenics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Anagenics Appoints CEO	03-08	MT
Anagenics Limited Announces Board Executive Changes	01/10/23	CI
Anagenics Appoints CEO/Managing Director	29/03/23	MT
Anagenics Limited Appoints Scott Greasley as Managing Director, Effective from 1 April 2023	28/03/23	CI
Anagenics Limited Announces CEO Changes	28/03/23	CI
Anagenics Limited Appoints Karen Matthews as Non-Executive Director	13/02/23	CI
Anagenics Approves the Election of Mr. Alexander Beard as A Director	28/11/22	CI
Anagenics Limited Announces Resignation of Dennis Eck as Director	16/10/22	CI
Anagenics Limited Appoints Scott Mitchell Greasley as Director	08/07/22	CI
Anagenics Promotes Financial Controller to Acting CEO	01/03/22	MT
Anagenics Limited Appoints Matthew Dudek as Acting Chief Executive Officer, Effective 28 February 2022	28/02/22	CI
Anagenics Limited Appoints Mr. Alexander Beard as Director	15/02/22	CI
Anagenics Limited Announces Management Changes	15/02/22	CI
Anagenics Limited Announces Management Changes	15/02/22	CI
Cellmid Limited has Changed its Name to Anagenics Limited	15/12/21	CI
Cellmid Limited Appoints Phillip Christopher as Non-Executive Director, Effective 5 November 2021	02/11/21	CI
Cellmid Limited Announces Executive Changes	23/12/20	CI
Cellmid Limited Appoints Sarah Eck-Thompson as Director	02/12/20	CI
Cellmid Limited Announces Management Changes	20/10/20	CI
Cellmid Limited Appoints Dr. Dominic Burg as Chief Operating Officer Effective 1 July 2020	01/06/20	CI

No results for this search